• 2011

Company Description

Esanex is a drug development company that focuses on advancing its highly selective and orally active Hsp90 inhibitors. 

Esanex is a drug development company focused on advancing its highly selective, orally active Hsp90 inhibitors. SNX-5422, created from a novel chemical scaffold that is unique in the Hsp90 field, has shown outstanding pre-clinical activity in a number of tumor models and is currently completing Phase 1 trials.

  • Manufacturer:

    Information Technology
  • Formed:

    2011
  • Company Website:

  • Company E-mail:

  • Company Address:

    115 W. Washington Street, SUITE 1680 SOUTH TOWER
    Indianapolis, IN
    United States
  • We recognize our sponsors starting at $1 per entry.
    Learn more at https://www.ithistory.org/benefits